New Data Support Long-Term Use Of AMBIEN CRTM (zolpidem Tartrate Extended- Release) Tablets C(IV) For Up To 24 Weeks
Fri, 14 Jul 2006 06:00 AM EST
... Sanofi-aventis(Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) today announcedresults from a study that demonstrated AMBIEN CR is well-tolerated andeffective in improving sleep onset and maintenance for up to six months inpatients with chronic primary insomnia when taken as needed for up to sevennights per week, without rebound insomnia following discontinuation. [click link for full article] ...
Related Topics
- Zolpidem
- Long Term Care
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Data & Statistics
- Loratadine and Pseudoephedrine
- Acute Care
- Data Analysis
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- National Data
- Niacin Extended Release
- Lovastatin Extended Release
- Isradipine Extended-Release Tablets
- Long Term Care/ltc
- Valproic Acid Delayed or Extended-Release or Sprinkle Capsule
- Metformin Extended-Release
- Pseudoephedrine Extended Release
- Fexofenadine and Pseudoephedrine
- Nursing Home Care
- Bupropion Extended-Release
- Chlorpromazine Extended-Release Capsules

Not Signed In -

